Home › U.S. FDA approves Durata's acute bacterial skin infection drug
 

Keywords :   


U.S. FDA approves Durata's acute bacterial skin infection drug

2014-05-24 01:29:08| Biotech - Topix.net

The U.S. Food and Drug Administration said on Friday it has approved a new drug to treat acute bacterial skin infections made by Durata Therapeutics Inc. Approval of the drug, Dalvance, follows a positive recommendation by the FDA's advisory committee, which also gave a favorable review to a rival product from Cubist Pharmaceuticals Inc. The FDA is ... (more)

Tags: skin drug acute infection

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Farm Progress America, May 20, 2024
20.05Farm Progress America, May 20, 2024
20.05Nielsen launches The Media Distributor Gauge
20.05Minerva AI Companion enhances the TV viewing experience
20.05Ryanair profits surge after fares climb by 20%
20.05SES Ethiosat delivering content to 95% of TV homes in Ethiopia
20.05Vidzemes TV expands with PlayBox Neo Channel-in-a-Box playout
20.05ocilion enhances user experience with Simply.TV metadata
More »